Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$17,020,366
-$37,073,193 QoQ
Shares Held
870,162
-49.9% QoQ
Ownership
0.844%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. VRDN ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in VRDN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,020,366 | 870,162 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $54,093,559 | 1,738,225 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $4,142,084 | 191,941 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,801,126 | 200,367 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,607,393 | 341,795 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,169,311 | 739,140 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $22,974,744 | 1,009,879 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,170,612 | 320,570 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $9,850,088 | 562,541 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $11,432,340 | 524,901 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $5,119,306 | 333,723 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,657,658 | 69,679 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,018,925 | 433,134 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,794,168 | 335,302 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,379,182 | 164,758 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $319,133 | 27,583 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $645,836 | 34,929 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $270,748 | 13,695 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $163,215 | 9,922 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $127,755 | 6,985 | Shares | Defined | 2021-08-23 | |
| No filing history on record for this holder in this stock. | ||||||